CTLA-4, PD-1 and TIM-3 expression predominantly downregulated in MS patients

被引:27
|
作者
Mohammadzadeh, Adel [1 ]
Rad, Isa Abdi [2 ]
Ahmadi-Salmasi, Babak [3 ]
机构
[1] Urmia Univ Med Sci, Dept Immunol & Genet, Orumiyeh, Iran
[2] Urmia Univ Med Sci, Dept Genet, Orumiyeh, Iran
[3] Urmia Univ Med Sci, Dept Neurol, Imam Khomeini Hosp, Orumiyeh, Iran
关键词
CTLA-4; PD-1; TIM-3; Multiple sclerosis; T-CELL-ACTIVATION; MULTIPLE-SCLEROSIS; ASSOCIATION; MECHANISMS; GALECTIN-9; INFECTION; PROMOTES; DISEASE;
D O I
10.1016/j.jneuroim.2018.08.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis (MS), is an autoimmune disorder of central nervous system (CNS) characterized by inflammation and demyelination. Self-tolerance impairment is considered to be induced by a combination of inherited susceptibility and environmental agents. In this work, we demonstrate that a reduction in the comparative expression of well-known inhibitory receptors (i.e., CTLA-4, PD-1, and TIM-3) is importantly linked with MS patients compared to healthy controls. The relative expression of interested genes was performed on peripheral blood mononuclear cells (PBMCs), by using quantitative real time-PCR (qRT-PCR). Our data high-lighted the role of inhibitory receptors in the maintenance of immune homeostasis in autoimmune disease.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 50 条
  • [41] High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer
    Baran Mollavelioglu
    Esin Cetin Aktas
    Neslihan Cabioglu
    Aykhan Abbasov
    Semen Onder
    Selman Emiroglu
    Mustafa Tükenmez
    Mahmut Muslumanoglu
    Abdullah Igci
    Gunnur Deniz
    Vahit Ozmen
    World Journal of Surgical Oncology, 20
  • [42] PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas
    Porcellato, Ilaria
    Mecocci, Samanta
    Brachelente, Chiara
    Cappelli, Katia
    Armando, Federico
    Tognoloni, Alessia
    Chiaradia, Elisabetta
    Stefanetti, Valentina
    Mechelli, Luca
    Pepe, Marco
    Gialletti, Rodolfo
    Passeri, Benedetta
    Ghelardi, Alessandro
    Razzuoli, Elisabetta
    ANIMALS, 2021, 11 (07):
  • [43] PD-L1, PD-1, and CTLA-4 Expression in Invasive Breast Cancer in Young Women
    Obeidin, Farres
    Pincus, Jennifer
    Siziopikou, K. P.
    Blanco, Luis
    LABORATORY INVESTIGATION, 2019, 99
  • [44] PD-L1, PD-1, and CTLA-4 Expression in Invasive Breast Cancer in Young Women
    Obeidin, Farres
    Pincus, Jennifer
    Siziopikou, K. P.
    Blanco, Luis
    MODERN PATHOLOGY, 2019, 32
  • [45] PD-L1, TIM-3, and CTLA-4 Blockade Fails To Promote Resistance to Secondary Infection with Virulent Strains of Toxoplasma gondii
    Splitt, Samantha D.
    Souza, Scott P.
    Valentine, Kristen M.
    Castellanos, Brayan E.
    Curd, Andrew B.
    Hoyer, Katrina K.
    Jensen, Kirk D. C.
    INFECTION AND IMMUNITY, 2018, 86 (09)
  • [46] Toxicity of PD-1/CTLA-4 inhibitor immunotherapy among elderly patients.
    Kapoor, Vidit
    Rixe, Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] CTLA-4, PD-1, LAG3, TIM3 and TIGIT display distinct vesicular distributions in murine T cells
    Lu, Jiahe
    Simonetti, Boris
    Veler, Alisa
    Cross, Stephen
    Ruan, Xiongtao
    Raj, Timsse
    Dowsey, Andrew
    Murphy, Robert F.
    Verkade, Paul
    Cullen, Pete
    Wuelfing, Christoph
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1182 - 1182
  • [48] IMMUNOTHERAPY PD-1 says goodbye, TIM-3 says hello
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (04) : 203 - 203
  • [49] Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis
    Nakayama, Chieri
    Tanoue, Kiyonori
    Idichi, Tetsuya
    Shimomura, Hiroki
    Kita, Yoshiaki
    Hozaka, Yuto
    Shinden, Yoshiaki
    Matsushita, Daisuke
    Nakajo, Akihiro
    Arigami, Takaaki
    Mataki, Yuko
    Kurahara, Hiroshi
    Ohtsuka, Takao
    ANTICANCER RESEARCH, 2022, 42 (07) : 3373 - 3380
  • [50] Tim-3 and PD-1: Regulators of adaptive immunity in multiple sclerosis
    Burman, Joachim
    Svensson, Emma
    Fransson, Moa
    Loskog, Angelica
    Mangsbo, Sara
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 141 - 141